trofosfamide has been researched along with Soft Tissue Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dörken, B; Kretzschmar, A; Pink, D; Reichardt, P; Thuss-Patience, PC; Tilgner, J | 1 |
Egerer, G; Ho, AD; Kasper, B | 1 |
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
1 trial(s) available for trofosfamide and Soft Tissue Neoplasms
Article | Year |
---|---|
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
2 other study(ies) available for trofosfamide and Soft Tissue Neoplasms
Article | Year |
---|---|
Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms | 2002 |
A new therapeutic approach in patients with advanced sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Female; Humans; Lactones; Male; Middle Aged; Neovascularization, Pathologic; Palliative Care; Pilot Projects; Pioglitazone; Sarcoma; Soft Tissue Neoplasms; Sulfones; Thiazolidinediones; Treatment Outcome | 2005 |